Literature DB >> 9834123

A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate.

K Tangemann1, M D Gunn, P Giblin, S D Rosen.   

Abstract

The homing of lymphocytes to secondary lymphoid organs is thought to involve the action of chemokines. Secondary lymphoid-tissue chemokine (SLC), a high endothelial venule (HEV)-associated chemokine, has emerged as a candidate for participating in this process. We now show that immobilized SLC strongly induces beta2 integrin-mediated binding of T lymphocytes of naive phenotype and B lymphocytes to ICAM-1 under static conditions. This effect is not mediated by beta2 integrin affinity modulation, because SLC does not elicit a beta2 integrin activation epitope (mAb24) on naive T lymphocytes. In a parallel plate flow chamber, lymphocytes rolling via L-selectin are rapidly arrested through beta2 integrins in a pertussis toxin-sensitive manner on a substrate consisting of L-selectin ligands (peripheral lymph node addressins) together with ICAM-1 and SLC. Naive T lymphocytes are arrested on the HEV substrate with sixfold higher efficiency than memory cells. Neutrophils roll, but are not arrested by SLC, whereas they respond to immobilized IL-8 with rapid arrest. Thus, our artificial HEV system recapitulates critical features of lymphocyte interactions with HEV in vivo. These observations strongly point to the participation of SLC in homing of lymphocytes to secondary lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  The state diagram for cell adhesion mediated by two receptors.

Authors:  Sujata K Bhatia; Michael R King; Daniel A Hammer
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

Review 3.  L-Selectin ligands in lymphoid tissues and models of inflammation.

Authors:  Adil I Khan; R Clive Landis; Rajneesh Malhotra
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

Review 4.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Adhesive dynamics simulation of G-protein-mediated chemokine-activated neutrophil adhesion.

Authors:  Kelly E Caputo; Daniel A Hammer
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

6.  Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.

Authors:  Kristina M DiFranco; Anukriti Gupta; Lindsey E Galusha; Jarelys Perez; To-Vy K Nguyen; Camille D Fineza; Scott C Kachlany
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

Review 7.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

Authors:  C Caux; S Ait-Yahia; K Chemin; O de Bouteiller; M C Dieu-Nosjean; B Homey; C Massacrier; B Vanbervliet; A Zlotnik; A Vicari
Journal:  Springer Semin Immunopathol       Date:  2000

8.  Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells.

Authors:  James M Coghill; Michael J Carlson; Angela Panoskaltsis-Mortari; Michelle L West; Joseph E Burgents; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

9.  Stimulation of naïve T-cell adhesion and immunological synapse formation by chemokine-dependent and -independent mechanisms.

Authors:  Shannon K Bromley; Michael L Dustin
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 10.  Modulating the intestinal immune system: the role of lymphotoxin and GALT organs.

Authors:  T W Spahn; T Kucharzik
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.